FDA Clearance Tracker · P040050-S012
Macroplastique Implants
Last checked: Nov 20, 2026Latest source record: Jul 15, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Jul 15, 2019
Approved
Time to decision
89 days
Received Apr 17, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P040050-S012
- Device name
- Macroplastique Implants
- Applicant
- Uroplasty, LLC
- Applicant location
- Minnetonka, MN
- Received
- Apr 17, 2019
- Decided
- Jul 15, 2019
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P040050
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
Approval for a modified formulation of the polymer resin used in the syringe barrel.
Source documents
Other decisions for Uroplasty, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.